Посещений:
Glycosylation and Disease | |
Glycosylation is the process of attachment of sugars to proteins and lipids to form the glyoproteins and glycolipids found in eukaryotic organisms. The presence of oligosaccharides on a protein can have substantial effects on its size, stability, charge and antigenicity. Altered glycosylation is implicated in cancer, mucosal diseases and pathogen–host interactions.
Posttranslational Modification and Human Disorders
G Brian Wisdom
Published Online ELS : 27 JAN 2006
(Рис.1.) | Major types of asparagine-linked (N-linked) saccharide structures in glycoproteins. Asn, asparagine; GlcNAc, N-acetyl-D-glucosamine; Man, mannose; Fuc, fucose. ... (Рис.2.) | Possible pathways of O-glycosylation. Fuc, fucose; Gal, D-galactose; GalNAc, N-acetyl-D-galactosamine; GlcNAc, N-acetyl-D-glucosamine; SA, sialic acid; SO4, sulfate; Ser, serine; Thr, threonine. ... (Рис.3.) | Major types of glycolipids. Cer, ceramide (N-fatty acyl sphingosine); Gal, D-galactose; Glc, D-glucose; GlcNH2, D-glucosamine; GlcNAc, N-acetyl-D-glucosamine; Man, mannose; PI, phosphatidylinositol. ... (Рис.4.) | Causes and consequences of altered epithelial glycosylation, using increased expression of galactose ?1>3 N-acetylgalactosamine ?- (Thomsen Friedenreich (TF) blood group antigen) as an example.(a) PNA histochemistry of colon cancer. The TF antigen (Gal?1-3GalNAc?-) acts as an oncofetal carbohydrate antigen with increased expression in the normal fetus, in precancerous change and in cancer, ... References Agrawal B, Krantz MJ, Reddish MA and Longenecker BM (1998) Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2. Nature Medicine 4: 43–49. Bresalier RS, Ho SB and Schoeppner HL et al. (1996) Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis. Gastroenterology 110: 1354–1367. Bresalier RS, Mazurek N, Sternber LR et al. (1998) Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding galectin-3. Gastroenterology 115: 287–296. Corfield AP, Myersough N, Gough M, Brochhausen I, Schauer R and Paraskeva C (1995) Glycosylation patterns of mucins in colonic disease. Biochemical Society Transactions 23: 840–845.< >Davril M, Degroote S, Humbert P et al. (1999) The sialylation of bronchial mucins secreted by patients suffering from cystic fibrosis or from chronic bronchitis is related to the severity of airway infection. Glycobiology 9: 311–321. Goupille C, Hallouin F, Meflah K and Le Pendu J (1997) Increase of rat colon carcinoma cells tumorigenicity by alpha(1-2) fucosyltransferase gene transfection. Glycobiology 7: 221–229. Granert C, Raud J, Xie X, Lindquist L and Lindbom L (1994) Inhibition of leukocyte rolling with polysaccharide fucoidin prevents pleocytosis in experimental meningitis in the rabbit. Journal of Clinical Investigation 93: 929–936. Hakomori SI (1993) Structure and function of sphingoglycolipids in transmembrane signalling and cell–cell interactions. Biochemical Society Transactions 21: 583–595. Hakomori S (1996) Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Research 56: 5309–5318. Karlen P, Young E, Brostrom O et al. (1998) Sialyl-Tn antigen as a marker of colon cancer risk in ulcerative colitis: relation to dysplasia and DNA aneuploidy. Gastroenterology 115: 1395–1404. Kojima N, Fenderson BA, Stroud MR et al. (1994) Further studies on cell adhesion based on Lex–Lex interaction with new approaches: embryoglycan aggregation of F9 teratocarcinoma cells, and adhesion of various tumour cells based on Lex expression. Glycoconjugate Journal 11: 238–248. Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA and Sim RB (1995) Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nature Medicine 1: 237–243. Matthijs G, Schollen E, Pardon E et al. (1997) Mutations in PMMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome. Nature Genetics 16: 88–92. McConville MJ and Ferguson MA (1993) The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes. Biochemical Journal 294: 305–324. Nelson RM, Cecconi O, Roberts WG, Aruffo A, Linhardt RJ and Revilacqua MP (1993) Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation. Blood 82: 3253–3258. Ohkura T, Fukushima K, Kurisaki A et al. (1997) A partial deficiency of dehydrodolichol reduction is a cause of carbohydrate-deficient glycoprotein syndrome type 1. Journal of Biological Chemistry 272: 6868–6875. Pienta KJ, Naik H, Akhtar A et al. (1995) Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. Journal of the National Cancer Institute 87: 348–353. Raza MW, Blackwell CC, Molyneux P et al. (1991) Association between secretor status and respiratory viral illness. British Medical Journal 303: 815–818. Rhodes JM (1996) Unifying hypothesis for inflammatory bowel disease and related colon cancer: sticking the pieces together with sugar. Lancet 347: 40–44. Ryder SD, Jacyna MR, Levi AJ, Rizzi PM and Rhodes JM (1998) Eating peanuts increases rectal proliferation in individuals with mucosal expression of peanut lectin receptor. Gastroenterology 114: 44–49. Thomas JR, Dwek RA and Rademacher TW (1990) Structure, biosynthesis and function of glycosylphosphatidylinositols. Biochemistry 29: 5413–5422. Vavasseur F, Dole K, Yang J et al. (1994). O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. European Journal of Biochemistry 222: 415–424. Von Itzstein M, Wu WY, Kok GB et al. (1993) Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363: 418–423. Yoshimura M, Ihara Y, Matsuzawa Y and Taniguchi N (1996) Aberrant glycosylation of E-cadherin enhances cell–cell binding to suppress metastasis. Journal of Biological Chemistry 271: 13811–13815. Yu LG, Fernig DG, White MRH et al. (1999) Edible mushroom (Agaricus bisporus) lectin, which reversibly inhibits epithelial cell proliferation, blocks NLS-dependent nuclear protein import. Journal of Biological Chemistry 274: 4890–4899. Zheng M, Fang H and Hakomori S (1994) Functional role of N-glycosylation in ?5?1 integrin receptor: de-N-glycosylation induces dissociation or altered association of ?5 and ?1 subunits and concomitant loss of fibronectin binding activity. Journal of Biological Chemistry 269: 12325–12331. Further Reading Bhavanadan VP and Furukawa K (1995) Biochemistry and oncology of sialoglycoproteins. In: Rosenberg A (ed.) Biology of the Sialic Acids, pp. 145–196. New York: Plenum Press. Brockhansen I, Schutzbach J and Kuhns W (1998) Glycoproteins and their relationship to human disease. Acta Anatomica (Basel) 161: 36–78. Corfield AP, Myerscough N, Gough M, Brockhausen I, Schauer R and Paraskeva C (1995) Glycosylation patterns of mucins in colonic disease. Biochemical Society Transactions 23: 840–845. Freeze HH (1998) Disorders in protein glycosylation and potential therapy: tip of an iceberg? Journal of Pediatrics 133: 593–600. Karlsson K-A (1998) Meaning and therapeutic potential of microbial recognition of host glycoconjugates. Molecular Microbiology 29: 1–11. Kim YS and Varki A (1997) Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconjugate Journal 14: 569–576. McDowell G and Gahl WA (1997) Inherited disorders of glycoprotein synthesis: cell biological insights. Proceedings of the Society for Experimental Biology and Medicine 215: 145–157. Rhodes JM (1997) Mucins and inflammatory bowel disease. Quarterly Journal of Medicine 90: 79–82. Taylor-Papadimitriou J and Epenetos AA (1994) Exploiting altered glycosylation patterns in cancer: progress and challenges in diagnosis and therapy. Trends in Biotechnology 12: 227–233. Wright A and Morrison SL (1997) Effect of glycosylation on antibody function: implications for genetic engineering. Trends in Biotechnology 15: 26–32. | |
Martin Dalziel, Max Crispin, Christopher N. Scanlan, Nicole Zitzmann, Raymond A. Dwek Emerging Principles for the Therapeutic Exploitation of Glycosylation Science 3 January 2014: Vol. 343 no. 6166 1235681 |